Adagrasib

Item number	Size	Delivery time	Price
TGM-T8369-5mg	5 mg	7 - 10 business days*	60.00€
TGM-T8369-1mL	1 ml	7 - 10 business days*	93.00€
TGM-T8369-10mg	10 mg	7 - 10 business days*	93.00€
TGM-T8369-25mg	25 mg	7 - 10 business days*	198.00€
TGM-T8369-50mg	50 mg	7 - 10 business days*	367.00€
TGM-T8369-100mg	100 mg	7 - 10 business days*	552.00€
TGM-T8369-500mg	500 mg	7 - 10 business days*	996.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Adagrasib (MRTX849) is an orally active and selective covalent inhibitor of KRAS... more

Close menu

Product information "Adagrasib"

Description: Adagrasib (MRTX849) is an orally active and selective covalent inhibitor of KRAS G12C. Adagrasib binds to the GDP state of the inactive conformation of KRAS G12C and inhibits KRAS and its downstream signaling. Adagrasib exhibits inhibitory activity against KRAS G12C mutant tumors. Target: Ras. Smiles: CN1CCC[C@H]1COc1nc2CN(CCc2c(n1)N1CCN([C@@H](CC#N)C1)C(=O)C(F)=C)c1cccc2cccc(Cl)c12. References: Hallin J, et al. The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients. Cancer Discov. 2020 Jan,10(1):54-71.

Keywords:	MRTX849
Supplier:	TargetMol
Supplier-Nr:	T8369

Properties

Application:	Targets GTPase KRas (KRAS, KRAS2)
MW:	604.12 D
Formula:	C32H35ClFN7O2
Format:	32160405

Database Information

CAS :	2326521-71-3\| Matching products
KEGG ID :	K07827 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Adagrasib"

Write a review